# EDGAR Filing Document

**Accession Number:** 0000049071
**File Stem:** 0000049071-26-000013
**Filing Date:** 2026-4
**Character Count:** 9956
**Document Hash:** 429971f56e9aed9966880b2a8230ee12
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000049071-26-000013.hdr.sgml**: 20260410

**ACCESSION NUMBER**: 0000049071-26-000013

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20260410

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20260410

**DATE AS OF CHANGE**: 20260410

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HUMANA INC
- **CENTRAL INDEX KEY:** 0000049071
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOSPITAL & MEDICAL SERVICE PLANS [6324]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 610647538
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05975
- **FILM NUMBER:** 26855336

**BUSINESS ADDRESS:**
- **STREET 1:** 101 E. MAIN STREET
- **CITY:** LOUISVILLE
- **STATE:** KY
- **BUSINESS PHONE:** 5025801000

**MAIL ADDRESS:**
- **STREET 1:** 101 E. MAIN STREET
- **CITY:** LOUISVILLE
- **STATE:** KY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EXTENDICARE INC
- **DATE OF NAME CHANGE:** 19740404

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HERITAGE HOUSE OF AMERICA INC
- **DATE OF NAME CHANGE:** 19671129

?xml version='1.0' encoding='ASCII'? hum-20260410

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of** 

**The Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): April 10, 2026 (April 10, 2026)**

**Humana Inc.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-5975** | **61-0647538** |
| **(State or other jurisdiction of incorporation)** | **(Commission File Number)** | **(IRS Employer Identification No.)** |

---

**101 East Main Street, Louisville, Kentucky 40202**

**(Address of principal executive offices, including zip code)**

**(502) 580-1000**

**(Registrant's telephone number, including area code)**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol</u>** | **<u>Name of each exchange on which registered</u>** |
| Common Stock | HUM | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

(d) On April 10, 2026, the Board of Directors (the "Board") of Humana Inc. (the "Company") expanded its number of authorized directors from ten to eleven and elected Robert S. Field as a director of the Company, in each case effective immediately following the adjournment of the Humana Inc. 2026 Annual Meeting of Stockholders on April 16, 2026.

The Board of Directors has determined Mr. Field qualifies as an independent director under the New York Stock Exchange's director independence standards.

Mr. Field will be compensated in accordance with the Company's director compensation program, the components of which are disclosed in the Company's proxy statement relating to 2026 Annual Meeting of Stockholders filed with the U.S. Securities and Exchange Commission on March 6, 2026. In accordance with this program, Mr. Field will be granted restricted stock units (RSUs) in connection with his election to the Board.

Mr. Field will be compensated in accordance with the Company's director compensation program, the components of which are disclosed in the Company's proxy statement relating to 2026 Annual Meeting of Stockholders filed with the U.S. Securities and Exchange Commission on March 6, 2026. In accordance with this program, Mr. Field will be granted restricted stock units (RSUs) in connection with his election to the Board.

No determination has yet been made regarding the appointment of Mr. Field to any committees of the Board. Except as otherwise disclosed herein, there are no arrangements between Mr. Field and any other person pursuant to which Mr. Field was elected to serve as a director, nor are there any transactions to which the Company or any of its subsidiaries is a party and in which Mr. Field has a material interest.

No determination has yet been made regarding the appointment of Mr. Field to any committees of the Board. Except as otherwise disclosed herein, there are no arrangements between Mr. Field and any other person pursuant to which Mr. Field was elected to serve as a director, nor are there any transactions to which the Company or any of its subsidiaries is a party and in which Mr. Field has a material interest.

On April 10, 2026, the Company issued a press release announcing the election of Mr. Field, a copy of which is attached hereto as Exhibit 99.1, and is incorporated by reference herein.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits:

---

| | |
|:---|:---|
| **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Exhibit No.</u>** | **<u>Description</u>** |
| <u>[99.1](exhibit991newsrelease1.htm)</u> | <u>[P](exhibit991newsrelease1.htm)[ress Release](exhibit991newsrelease1.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **HUMANA INC.** | **HUMANA INC.** |
| **BY:** | **/s/ Valerie M. Talkers** |
| | **Valerie M. Talkers** |
| | **Vice President, Associate General Counsel & Corporate Secretary** |

---

Dated: April 10, 2026

## Exhibit 99.1

**n e w s** r e l e a s e<br>

![humanalogo.jpg](humanalogo.jpg)

**Exhibit 99.1**

---

| | |
|:---|:---|
| &nbsp;&nbsp;**FOR MORE INFORMATION CONTACT:** | &nbsp;&nbsp;**FOR MORE INFORMATION CONTACT:** |
| &nbsp;&nbsp;**Investors:** | Lisa Stoner - Humana Investor Relations; (502) 580-2652;<br><u>lstamper@humana.com</u> |
| &nbsp;&nbsp;**Media:** | Mark Taylor - Humana Corporate Communications; (317) 753-0345; <br><u>mtaylor108@humana.com</u> |

---

**Humana Elects Robert S. Field to Board of Directors**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Field is the Principal and Managing Member of ηMed Capital Management LLC, an investment firm focused on U.S. healthcare services companies, primarily in the managed care industry.* 

**LOUISVILLE, KY. (April 10, 2026)** — Humana Inc. (NYSE: HUM) announced today that Robert S. Field has been elected as a member of the Company's Board of Directors, effective immediately following the Company's 2026 Annual Meeting of Stockholders.

Field is the Principal and Managing Member of ηMed Capital Management LLC, an investment firm focused on U.S. healthcare services companies, primarily in the managed care industry. He previously served as a senior analyst at Luxor Capital, a multi-strategy investment fund, where he led healthcare services investments. Earlier in his career, Field worked as an associate at McKinsey & Company, focused on corporate and business strategy and previously practiced antitrust law at Vinson & Elkins LLP.

"We are pleased to welcome Rob and are confident that the investor perspective he has developed over more than two decades as a healthcare investor will bring meaningful insight to our Board," said Humana Chairman of the Board Kurt J. Hilzinger." His deep expertise across investment evaluation, risk oversight, and capital allocation —along with his strong understanding of legal and regulatory dynamics in the healthcare sector — will be valuable as Humana executes on its strategy to drive profitable, sustainable growth and long-term shareholder value."

Field's appointment follows a comprehensive search process led by the Humana Board and informed by shareholder engagement, including helpful input from John Petry, Managing Member of Sessa Capital, as part of the Company's ongoing commitment to Board refreshment and strong corporate governance.

------

**<u>About Humana</u>**

Humana is a leading U.S. healthcare company. Through our Humana insurance services, and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at <u>Humana.com</u> and at <u>CenterWell.com</u>.

\# \# \#

<br>